No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
LFCR Lifecore Biomedical
- 7.240
- +0.170+2.40%
Close Dec 20 16:00 ET
- 7.239
- -0.001-0.01%
Post 20:01 ET
266.63MMarket Cap51.71P/E (TTM)
7.360High7.030Low761.67KVolume7.050Open7.070Pre Close5.50MTurnover3.56%Turnover Ratio22.63P/E (Static)36.83MShares8.90052wk High-67.66P/B155.00MFloat Cap3.67952wk Low--Dividend TTM21.41MShs Float16.750Historical High--Div YieldTTM4.67%Amplitude1.510Historical Low7.225Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
Here's Why Arquitos Capital Management Largely Exited Lifecore (LFCR)
Lifecore Biomedical (NASDAQ:LFCR) Investors Are Sitting on a Loss of 33% If They Invested Five Years Ago
Express News | Lifecore Biomedical Amends and Extends Revolving Credit Facility With BMO
Press Release: Lifecore Biomedical Amends and Extends Revolving Credit Facility With BMO
Heat List
US
Overall
Symbol
Price
% Chg
No Data